CenterBook Partners LP Makes New $5.08 Million Investment in Cardinal Health, Inc. $CAH

CenterBook Partners LP bought a new position in Cardinal Health, Inc. (NYSE:CAH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 24,697 shares of the company’s stock, valued at approximately $5,075,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Aventura Private Wealth LLC purchased a new stake in shares of Cardinal Health in the 4th quarter valued at about $25,000. Palladiem LLC purchased a new stake in shares of Cardinal Health in the 4th quarter valued at about $28,000. Elyxium Wealth LLC purchased a new stake in shares of Cardinal Health in the 4th quarter valued at about $34,000. Barnes Dennig Private Wealth Management LLC raised its holdings in shares of Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after acquiring an additional 53 shares in the last quarter. Finally, JPL Wealth Management LLC purchased a new stake in shares of Cardinal Health in the 3rd quarter valued at about $31,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.0%

Shares of NYSE CAH opened at $205.79 on Monday. The stock has a market cap of $48.20 billion, a price-to-earnings ratio of 31.47, a P/E/G ratio of 1.12 and a beta of 0.52. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The stock’s 50-day moving average is $202.53 and its 200 day moving average is $208.59.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.Cardinal Health’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period last year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s payout ratio is presently 31.19%.

Wall Street Analyst Weigh In

Several analysts have weighed in on CAH shares. Evercore lowered their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. Citigroup decreased their price objective on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Finally, Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.